{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:44:09Z","timestamp":1781063049177,"version":"3.54.1"},"reference-count":39,"publisher":"CMA Impact Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["cmajo"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.9778\/cmajo.20220104","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T12:15:11Z","timestamp":1687263311000},"page":"E537-E545","source":"Crossref","is-referenced-by-count":8,"title":["Opioid-related emergency department visits and deaths after a harm-reduction intervention: a retrospective observational cohort time series analysis"],"prefix":"10.9778","volume":"11","author":[{"given":"Matthew E.M.","family":"Yeung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chel Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"382","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"2024060705350502000_11.3.E537.1","unstructured":"Opioid- and stimulant-related harms in Canada (Public Health Agency of Canada, Ottawa) modified 2022 Dec. 14. Available: https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants . accessed 2021 July 7."},{"key":"2024060705350502000_11.3.E537.2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12961-020-00596-8","article-title":"The opioid crisis: a contextual, social-ecological framework","volume":"18","author":"Jalali","year":"2020","journal-title":"Health Res Policy Syst"},{"key":"2024060705350502000_11.3.E537.3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1360-0443.2009.02837.x","article-title":"The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia","volume":"105","author":"Salmon","year":"2010","journal-title":"Addiction"},{"key":"2024060705350502000_11.3.E537.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62353-7"},{"key":"2024060705350502000_11.3.E537.5","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/add.15717","article-title":"Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis","volume":"117","author":"Kennedy","year":"2022","journal-title":"Addiction"},{"key":"2024060705350502000_11.3.E537.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f174"},{"key":"2024060705350502000_11.3.E537.7","doi-asserted-by":"crossref","first-page":"107536","DOI":"10.1016\/j.drugalcdep.2019.06.038","article-title":"Impact of a community-based naloxone distribution program on opioid overdose death rates","volume":"204","author":"Naumann","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2024060705350502000_11.3.E537.8","unstructured":"Pearson H Gilligan M (May 27, 2021) Global News, Calgary\u2019s supervised consumption site at Sheldon Chumir centre to close, services being relocated. updated 2021 May 28. Available: https:\/\/globalnews.ca\/news\/7900839\/calgary-sheldon-chumir-supervised-consumption-site-relocation\/ . accessed 2022 Apr. 4."},{"key":"2024060705350502000_11.3.E537.9","unstructured":"Opinko D (Aug 12, 2020) LethbridgeNewsNow, ARCHES announces closure of Lethbridge\u2019s supervised consumption site. Available: https:\/\/lethbridgenewsnow.com\/2020\/08\/12\/breaking-arches-announces-closure-of-lethbridges-supervised-consumption-site\/ . accessed 2022 Apr. 4."},{"key":"2024060705350502000_11.3.E537.10","unstructured":"Mohatarem KF (Apr 28, 2021) CBC News, Boyle Street supervised consumption site closing permanently. Available: https:\/\/www.cbc.ca\/news\/canada\/edmonton\/edmonton-boyle-street-supervised-consumption-1.6005939 . accessed 2022 Apr. 4."},{"key":"2024060705350502000_11.3.E537.11","unstructured":"Government of Alberta (2020) Impact: a socio-economic review of supervised consumption sites in Alberta (Edmonton, AB) Available: https:\/\/open.alberta.ca\/dataset\/dfd35cf7-9955-4d6b-a9c6-60d353ea87c3\/resource\/11815009-5243-4fe4-8884-11ffa1123631\/download\/health-socio-economic-review-supervised-consumption-sites.pdf . accessed 2023 May 26."},{"key":"2024060705350502000_11.3.E537.12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12954-020-00456-2","article-title":"Supervised consumption sites and crime: scrutinizing the methodological weaknesses and aberrant results of a government report in Alberta, Canada","volume":"18","author":"Livingston","year":"2021","journal-title":"Harm Reduct J"},{"key":"2024060705350502000_11.3.E537.13","unstructured":"(2020) COVID-19 opioid response surveillance report (Government of Alberta, Edmonton) Available: https:\/\/open.alberta.ca\/dataset\/f4b74c38-88cb-41ed-aa6f-32db93c7c391\/resource\/e8c44bab-900a-4af4-905a-8b3ef84ebe5f\/download\/health-alberta-covid-19-opioid-response-surveillance-report-2020-q2.pdf . accessed 2021 Sept. 30."},{"key":"2024060705350502000_11.3.E537.14","unstructured":"(2020) Impacts of the COVID-19 pandemic on substance use treatment capacity in Canada (Canadian Centre on Substance Use and Addiction, Ottawa) Available: https:\/\/www.ccsa.ca\/sites\/default\/files\/2020-12\/CCSA-COVID-19-Impacts-Pandemic-Substance-Use-Treatment-Capacity-Canada-2020-en.pdf . accessed 2021 Sept. 30."},{"key":"2024060705350502000_11.3.E537.15","unstructured":"Card KG Pauly B Urbanoski K (2020) Using proximity analysis to study the impact of substance use services on local neighbourhoods (Canadian Institute for Substance Use Research, Victoria)."},{"key":"2024060705350502000_11.3.E537.16","unstructured":"Opioid response: options for care (Government of Alberta, Edmonton) Available: https:\/\/www.alberta.ca\/opioid-response-options-for-care.aspx . accessed 2022 Apr. 4."},{"key":"2024060705350502000_11.3.E537.17","unstructured":"Supervised consumption services (Alberta Health Services, Edmonton) Available: https:\/\/www.albertahealthservices.ca\/info\/Page15434.aspx . accessed 2022 Apr. 4."},{"key":"2024060705350502000_11.3.E537.18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/1715163520958435","article-title":"The status of naloxone in community pharmacies across Canada","volume":"153","author":"So","year":"2020","journal-title":"Can Pharm J (Ott)"},{"key":"2024060705350502000_11.3.E537.19","unstructured":"(2020) ACCH report: report on the effectiveness of the community-based take home naloxone program (Alberta Community Council on HIV, StonyPlain (AB)) Available: https:\/\/northreach.ca\/wp-content\/uploads\/2020\/06\/2020-05-20-A-Report-on-the-Community-Based-Take-Home-Naloxone-Program-Effectiveness.pdf . accessed 2022 Aug. 19."},{"key":"2024060705350502000_11.3.E537.20","first-page":"4","article-title":"Community-based naloxone: a Canadian pilot program","volume":"3","author":"Dong","year":"2012","journal-title":"Can J Addict"},{"key":"2024060705350502000_11.3.E537.21","unstructured":"Frequently asked questions for pharmacists (Alberta Health Services, Edmonton) updated May 2019. Available: https:\/\/www.albertahealthservices.ca\/assets\/healthinfo\/mh\/hi-amh-cbn-program-frequently-asked-questions-pharmacists.pdf . accessed 2021 Sept. 30."},{"key":"2024060705350502000_11.3.E537.22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/pon.3656","article-title":"A randomized trial comparing live and telemedicine deliveries of an imagery-based behavioral intervention for breast cancer survivors: reducing symptoms and barriers to care","volume":"24","author":"Freeman","year":"2015","journal-title":"Psychooncology"},{"key":"2024060705350502000_11.3.E537.23","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1177\/0706743721999571","article-title":"The impact of supervised consumption services on fentanyl-related deaths: lessons learned from Alberta\u2019s provincial data","volume":"66","author":"Marshall","year":"2021","journal-title":"Can J Psychiatry"},{"key":"2024060705350502000_11.3.E537.24","unstructured":"National Center for Injury Prevention and Control (U.S.); Division of Unintentional Injury Prevention; Health Systems and Trauma Systems Branch (2013) Prescription drug overdose data and statistics: guide to ICD-9-CM and ICD-10 codes related to poisoning and pain (Centres for Disease Control and Prevention, Atlanta) Available: https:\/\/stacks.cdc.gov\/view\/cdc\/59394 . accessed 2021 Sept. 30."},{"key":"2024060705350502000_11.3.E537.25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.15171\/ijhpm.2015.73","article-title":"Examining the potential role of a supervised injection facility in Saskatoon, Saskatchewan, to avert HIV among people who inject drugs","volume":"4","author":"Jozaghi","year":"2015","journal-title":"Int J Health Policy Manag"},{"key":"2024060705350502000_11.3.E537.26","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.080808"},{"key":"2024060705350502000_11.3.E537.27","doi-asserted-by":"publisher","DOI":"10.1111\/add.14664"},{"key":"2024060705350502000_11.3.E537.28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugpo.2018.12.015","article-title":"The projected costs and benefits of a supervised injection facility in Seattle, WA, USA","volume":"67","author":"Hood","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2024060705350502000_11.3.E537.29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12954-017-0153-2","article-title":"Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility","volume":"14","author":"Irwin","year":"2017","journal-title":"Harm Reduct J"},{"key":"2024060705350502000_11.3.E537.30","doi-asserted-by":"crossref","first-page":"e1002964","DOI":"10.1371\/journal.pmed.1002964","article-title":"Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: a cohort study","volume":"16","author":"Kennedy","year":"2019","journal-title":"PLoS Med"},{"key":"2024060705350502000_11.3.E537.31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12905-021-01196-6","article-title":"Women\u2019s multiple uses of an overdose prevention technology to mitigate risks and harms within a supportive housing environment: a qualitative study","volume":"21","author":"Bardwell","year":"2021","journal-title":"BMC Womens Health"},{"key":"2024060705350502000_11.3.E537.32","doi-asserted-by":"crossref","unstructured":"Jackson J (2020) A cost analysis of overdose management at a supervised consumption site in Calgary, Canada (Qeios, London (UK)).","DOI":"10.32388\/J6MQ0E"},{"key":"2024060705350502000_11.3.E537.33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13722-022-00323-4","article-title":"Virtual opioid agonist treatment: Alberta\u2019s virtual opioid dependency program and outcomes","volume":"17","author":"Day","year":"2022","journal-title":"Addict Sci Clin Pract"},{"key":"2024060705350502000_11.3.E537.34","doi-asserted-by":"publisher","DOI":"10.1111\/add.13265"},{"key":"2024060705350502000_11.3.E537.35","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-2667(18)30044-6"},{"key":"2024060705350502000_11.3.E537.36","doi-asserted-by":"publisher","DOI":"10.1111\/add.13326"},{"key":"2024060705350502000_11.3.E537.37","unstructured":"(2016) Highlights of the Alberta economy (Government of Alberta, Edmonton) Available: https:\/\/open.alberta.ca\/dataset\/10989a51-f3c2-4dcb-ac0f-f07ad88f9b3b\/resource\/e68b9292-51d5-40e8-8151-d148bda6d473\/download\/2016-highlights-alberta-economy-2016-07.pdf . accessed 2021 Sept. 30."},{"key":"2024060705350502000_11.3.E537.38","unstructured":"Drug analysis service: trends 2012\u20132019 (Health Canada, Ottawa) modified 2020 Sept. 30. Available: https:\/\/www.canada.ca\/en\/health-canada\/services\/health-concerns\/controlled-substances-precursor-chemicals\/drug-analysis-service\/2019-drug-analysis-service-trends.html . accessed 2021 Sept. 30."},{"key":"2024060705350502000_11.3.E537.39","doi-asserted-by":"publisher","DOI":"10.24095\/hpcdp.38.6.02"}],"container-title":["CMAJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.9778\/cmajo.20220104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T12:35:37Z","timestamp":1717763737000},"score":1,"resource":{"primary":{"URL":"http:\/\/cmajopen.ca\/lookup\/doi\/10.9778\/cmajo.20220104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,6,20]]},"published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.9778\/cmajo.20220104"],"URL":"https:\/\/doi.org\/10.9778\/cmajo.20220104","relation":{},"ISSN":["2291-0026"],"issn-type":[{"value":"2291-0026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]}}}